companydata.dkcompanydata.dk

VEPIDAN ApS: Financial statements 2025

CVR: 17077848

Source: annual report 2025, Danish Business Authority

01/07/2024 – 30/06/2025

VEPIDAN ApS (CVR 17077848) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 5,846,932 and a net result of DKK 2,949,865 compared with DKK -1,241,820 the year before. That is an increase of 0.5% compared with the year before. Equity in the 2025 report amounted to DKK 109,259,532. The solvency ratio was 82.1%. The company had 24 employees in the financial year.

Gross Profit
DKK 5,846,932
Profit/Loss
DKK 2,949,865
Equity
DKK 109,259,532
Total Assets
DKK 133,077,326
Employees
24

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-5.8 mio.2.9 mio.109.3 mio.24
2024-5.8 mio.-1.2 mio.106.3 mio.23
2023-6.1 mio.-13.8 mio.107.6 mio.27
2022-4.5 mio.-5.8 mio.95.7 mio.27
2021-7.8 mio.37.6 mio.101.5 mio.27

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is VEPIDAN ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About VEPIDAN ApS

VEPIDAN ApS is a Danish company of the type Anpartsselskab based in Løgstør, founded in 1993. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ApS KBUS 8 NR. 3163. The management consists of Margarethe Bower. The company is owned by Hans Christian Graversen, Margarethe Bower and Peter Graversen. The company has 37 employees (2026). In 2025, the company reported a gross profit of DKK 5,846,932 and a net result of DKK 2,949,865 compared with DKK -1,241,820 the year before. Equity in the 2025 report amounted to DKK 109,259,532.

Source: annual report 2025, Danish Business Authority